Express Scripts 2012 Annual Report Download - page 2

Download and view the complete annual report

Please find page 2 of the 2012 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Financial Highlights
(in millions, except per share data) 20121 2011 % Change
Statement of Operations:
Revenues $ 93,858.1 $ 46,128.3 103%
Income before income taxes 2,191.0 2,027.1 8%
Net income from continuing operations 1,340.5 1,275.8 5%
Per Diluted Share Data:
Net income from continuing operations $ 1.79 $ 2.53 -29%
Average Diluted Shares Outstanding 747.3 505.0 48%
Balance Sheet Data:
Cash $ 2,793.9 $ 5,620.1 -50%
Total assets 58,111.2 15,607.0 272%
Total debt, including current maturities 15,915.0 8,076.3 97%
Stockholders’ equity 23,395.7 2,475.3 845%
Net Cash Provided by Operating Activities
–
continuing operations $ 4,752.2 $ 2,193.1 117%
Selected Data:
Total adjusted claims 1,395.7 751.5 86%
1 2012 financials include results from Medco upon consummation of the merger on April 2, 2012, including amortization of intangible assets.
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for millions of patients.
On behalf of our clients – employers, health plans, unions and government health programs – we make the use of
prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral
sciences, clinical specialization and actionable data – to create Health Decision ScienceSM, our innovative approach
to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean
healthier outcomes.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services,
including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design
consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The
company also distributes a full range of biopharmaceutical products and provides extensive cost-management
and patient-care services.
Keith Ebling
Executive Vice President & General Counsel
Jeff Hall
Executive Vice President &
Chief Financial Officer
Chris Houston
Senior Vice President,
Pharma & Retail Relations
Ed Ignaczak
Executive Vice President,
Sales & Marketing
Pat McNamee
Executive Vice President &
Chief Operating Officer
Steve Miller, MD
Senior Vice President &
Chief Medical Officer
George Paz
Chairman & Chief Executive Officer
Glen Stettin, MD
Senior Vice President,
Clinical, Research & New Solutions
Sara Wade
Senior Vice President &
Chief Human Resources Officer
Tim Wentworth
Senior Vice President & President,
Sales & Account Management
Gary Wimberly
Senior Vice President &
Chief Information Officer
Larry Zarin
Senior Vice President &
Chief Marketing Officer
Management Team